MedTrace Logo

Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population

NCT01142960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2016-05-12

No results posted yet for this study

Summary

With the rapid growing aging population, age-related eye diseases including cataract are becoming more prevalent. The demand for cataract surgery and post-surgical care posed enormous financial burdens to the government.

Lycium barbarum contains lutein and zeaxanthin which can filter the phototoxic blue light and neutralize the reactive oxygen species, thus provide a protective effect against cataract formation.

This study aims to determine the effects of Lycium barbarum Supplements on the progression of senile cataract in Hong Kong Chinese elderly.

Conditions

  • Lens Opacity

Interventions

DIETARY_SUPPLEMENT

Starch

1350mg/day

DIETARY_SUPPLEMENT

Lycium Barbarum

1350mg/day

Sponsors & Collaborators

  • The Hong Kong Jockey Club Charities Trust

    collaborator OTHER

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Chi-wai Do, PhD · The Hong Kong Polytechnic University

  • Chea-su Kee, PhD · The Hong Kong Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2012-04-30
Completion
2012-06-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01142960 on ClinicalTrials.gov